Effect of dysthymia on receipt of HAART by minority HIV-infected women
- 1 December 2006
- journal article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 21 (12), 1235-1241
- https://doi.org/10.1111/j.1525-1497.2006.00597.x
Abstract
BACKGROUND: Receipt of highly active antiretroviral therapy (HAART) differs by gender and racial/ethnic group and may reflect an effect of mood disorders. OBJECTIVE: We examined the effects of dysthymia and major depression on HAART use by 6 groups defined by gender and race/ethnicity (white, black, Hispanic). MAIN OUTCOME MEASURE: Self-reported HAART use in the past 6 months. DATA SOURCE: Interview data from the HIV Cost and Services Utilization Study (HCSUS). Independent variables measured in or before the first half of 1997, and HAART use measured in the second half of 1997. ANALYSES: Multivariate logistic regression of depression and dysthymia on HAART use by 6 patient groups. PARTICIPANTS: One thousand nine hundred and eighty-two HIV-infected adults in HIV care in 1996 and with a CD4 count RESULTS: Highly active antiretroviral therapy receipt was the highest for white men (68.6%) and the lowest for Hispanic women (52.7%) and black women (55.4%). Dysthymia was more prevalent in women (Hispanic, 46%; black, 27%; white, 31%) than men (Hispanic, 23%; black, 18%; white, 15%). The prevalence of major depression was greater in whites (women, 35%; men, 31%) than minorities (women, 26%; men, 21%). Compared with white men without dysthymia, the adjusted odds ratios (AORs) of HAART were significantly lower for black women (0.50 [95% confidence interval [95% CI] 0.29 to 0.87]) and Hispanic women (0.45 [95% CI 0.25, 0.79]). Among patients with depression and no dysthymia, minority women had HAART use (AOR=1.28 [95% CI 0.48 to 3.43]) similar to white men. LIMITATIONS: Self-report data from the early era of HAART use; causation cannot be proven; mental health diagnoses may not meet full DSM IV criteria. CONCLUSIONS: Dysthymia is highly prevalent in minority women and associated with a 50% reduction in the odds of receiving HAART. This underrecognized condition may contribute more than depression to the “gender disparity” in HAART use.Keywords
This publication has 42 references indexed in Scilit:
- Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive womenAIDS Care, 2006
- Prevalence of Depression by Race/Ethnicity: Findings From the National Health and Nutrition Examination Survey IIIAmerican Journal of Public Health, 2005
- Outpatient Patterns of Care and Longitudinal Intensity of Antiretroviral Therapy for HIV-Infected Drug UsersMedical Care, 2002
- Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA studyActa Psychiatrica Scandinavica, 2002
- Effect of Race and/or Ethnicity in Use of Antiretrovirals and Prophylaxis for Opportunistic Infection: A Review of the LiteraturePublic Health Reports, 2002
- Brief screening of psychiatric disorders among a national sample of HIV-positive adults: concordance between the Composite International Diagnostic Interview (CIDI) and the CIDI Short Form (CIDI-SF)International Journal of Methods in Psychiatric Research, 2001
- An Investigation of Why Eligible Patients Do Not Receive HAARTAIDS Patient Care and STDs, 2001
- Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF)International Journal of Methods in Psychiatric Research, 1998
- Development of Screeners for Depressive Disorders and Substance Disorder HistoryMedical Care, 1993